by Dom Partridge | May 6, 2025 | Industry insights
Written by Susan O’Connell and Sara Bartlome Introduction Systematic literature reviews (SLRs) seek to answer a specific research question by translating the question into search terms and developing a literature search strategy to effectively identify relevant...
by Dom Partridge | Feb 28, 2025 | Industry insights
Written by Aurore Sommer, Medical Writer A disease is considered to be rare when it affects fewer than 1 in 2,000 individuals. To this day, more than 6,000 rare diseases have been identified, affecting around 300 million people globally (1). Rare diseases are...
by Dom Partridge | Jan 23, 2025 | Industry insights
Written by Louisa Rutherford, Senior Systematic Review Analyst This blog explores the intersection of climate change and the health technology assessment (HTA) process. It examines how incorporating environmental impact data into the HTA process could help...
by Dom Partridge | Sep 26, 2024 | Industry insights
Written by Alys Ridsdale, Associate Systematic Review Analyst Introduction There are over 7,100 spoken languages across the globe (1). Despite this linguistic diversity, including language restrictions in a systematic literature review (SLR) is common practice...
by acaballero | Aug 8, 2024 | Industry insights
Written by Sneha Bhadti, David Pritchett, & Susan O’Connell The implementation of the European Union (EU) joint clinical assessment (JCA) process is fast approaching. In January 2025, the JCA will be rolled out for new oncology and orphan medications....
by Rachel Montague | Jul 15, 2024 | Industry insights
Written by Susan O’Connell, Louise Crathorne, & Sneha Bhadti In the realm of healthcare innovation, the European Union (EU) is paving the way with the Joint Clinical Assessment (JCA) process In this background article, Source aims to highlight some of the...
